With the spread of the human immune virus I (HIV-1), it is becoming increasingly common for pregnant women to be infected (table 1) . As a result of perinatal transmission, the number of infected offspring is consequently also increasing. Three possible routes of perinatal transmission have been considered.
In most instances the infection is presumably transmitted in utero. This conclusion is supported by a short incubation time after birth in some cases [1] , a high incidence of hepatosplenomegaly and low birth weight [2] , and the presence of foetopathy in children with acquired immune deficiency syndrome (AIDS) and AIDS-related complex (ARC) [1] . The dysmorphic features suggest exposure to the virus in the first trimester of pregnancy [1] . Isolation of HIV-l from a 20-week foetus [3] , detection of HIV-1 in cord blood [1, 4] or within 24 hours of birth [5] , and demonstration of the virus in infants delivered by caesarean section [6] are also taken as evidence. A second possible route of transmission is the contact of the neonate with infected blood from the mother at delivery.
Finally, consideration is being given to the possibility that breast milk can transfer HIV-1. The virus has been isolated from the cell-free clear middle layer from centrifuged milk from three seropositive mothers [7] . The cells in the milk could not be cultured for the virus because of bacterial contamination. The possible role of antibodies present in milk for infectivity of the virus or for its detection has not been studied. The capacity of the virus to infect by way of the intestinal tract, reaching its receptors on T4 cells, is not clear. However, about 15% of the many intra-epithelial lymphocytes in the gut mucosa are T4 cells.
It should be noted that human milk contains significant numbers of leukocytes. They reach a maximum three to four days after the onset of lactation, with from 500,000 to 10 million cells per millilitre. By four to six weeks after parturition, they are present at less than 100,000 per millilitre. The number of lymphocytes declines sharply within two to three days postpartum, whereas the number of macrophages declines less and remains at detectable levels. With increasing milk volumes they continue to be present [8] . It is likely but not yet demonstrated that such milk cells may be infected with HIV-1.
Only one case of transfer of HIV-1 from mother to baby has been published in which the transmission could have been through breast milk [9] . The mother was infected by a postpartum blood transfusion, and her infant became seropositive either due to the six weeks of breast-feeding or by some other close contact with the mother. Four other cases, from Rwanda and Zaire, not yet published, also suggest breast milk as the mode of transmission.
No definite data exist as to the relative frequency of different modes of transmission of HIV-1 from mother to offspring. Among 104 children in the United States with AIDS who were studied for disease transmission, the risk factors were as follows, in order of frequency: maternal risk factors, paternal risk factors, sexual abuse, and exposure to needles at home [1] . The majority were children of intravenous-drug-abusing mothers and/or fathers or children of bisexual fathers.
Although intrauterine infection from the mother may be most common, Chiodo et al. have described 12 babies from HIV-1 seropositive mothers, of whom 3 of 7 delivered normally became infected, but none of the 5 delivered by caesarean section did [10] . This could be taken to suggest that natural delivery increases the risk of perinatal transfer, but the matter certainly needs further study.
The risk for babies of seropositive mothers of developing ARC or AIDS varies according to different sources, with figures ranging from 15% to 50% for the first child and from 60% to 80% for later siblings [1; A. Nahmias, personal communication]. Only one of a pair of identical twins was infected in one instance [1] ; the healthy twin was followed for 10 months.
The risk of transfer of HIV-1 in breast milk
Few cases are known in which breast milk can have transferred HIV-1. Yet the risk cannot be discounted, and countries such as the United States [11] and Sweden are advising seropositive mothers not to breast-feed. It is also advised that human-milk banks should pasteurize their milk [12, 13] . Such advice can be followed in places where diagnostic tests for HIV-1 infection are readily available and where pasteurization can be arranged. In such areas it is likely that the risk of contracting various gastro-intestinal and respiratory-tract infections is limited, and decreased frequency of breast-feeding may not have disastrous effects.
The problem is much more serious, however, in areas where such infections are frequent and breast-feeding is very important in protecting against them. A recent estimate of mortality from various diseases in east Africa shows that approximately one person dies of AIDS in large cities for every 10 who die of diarrhoea, but in rural areas the proportion is only one death from AIDS for every 4,000 deaths from diarrhoea [14] , This illustrates the complexity of the problem. It might be added in this connection that the median relative risk of diarrhoea mortality is estimated to be about 25 times as high in non-breast-fed as in exclusively breast-fed infants.
With the limited information presently available concerning the risk of transfer of HIV-1 through breast milk, it seems of prime importance to propose research that can expand our knowledge. Specifically, it is important to determine whether or not those at risk of being infected through milk have not already been infected in utero. Any recommendations concerning breast-feeding in relation to AIDS must be provisional and temporary until additional information appears. It should be realized that today the mortality of infants from AIDS is still minimal compared to that from conditions such as diarrhoea. Diminished breast-feeding would make that difference even more striking .
